NDC 23155-735 – Terazosin

Terazosin Hydrochloride 1 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC23155-735

Product details

Brand name
Terazosin
Generic name
Terazosin
Labeler
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA075614
Marketed since
April 30, 2021
Listing expires
December 31, 2026
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Terazosin →

Package NDC codes (2)

Package NDCDescriptionSince
23155-735-01100 CAPSULE in 1 BOTTLE (23155-735-01)Apr 30, 2021
23155-735-101000 CAPSULE in 1 BOTTLE (23155-735-10)Apr 30, 2021

Other Terazosin products